Publication | Open Access
Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study
64
Citations
15
References
2019
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1